OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
April 02, 2008
Financial experts share their insights for the performance for innovator drug companies and generic-drug players.
Excipient producers and industry observers share their perspectives on innovation for excipients.
March 25, 2008
The US market for prescription pharmaceutical grow only 3.8% in 2007, the lowest growth rate in more than 40 years, according to a recent analysis by IMS Health.
March 20, 2008
The US Pharmacopeial Convention announced a revised glycerin monograph in the United States Pharmacopeia.
March 13, 2008
The US House of Representatives Committee on Homeland Security approved legislation last week that mandates inherently safer technologies (IST) as part of chemical-site security standards, a move that was opposed by the Synthetic Organic Chemical Manufacturers Association.
March 06, 2008
Merck & Co. advised AstraZeneca (London) that it will not exercise its option to sell its interest in certain AstraZeneca non-proton pump inhibitor (non-PPI) products this year.